Comprehensive next-generation profiling of clonal hematopoiesis in cancer patients using paired tumor-blood sequencing for guiding personalized therapies.
Short-Term Responders of Non-Small Cell Lung Cancer Patients to EGFR Tyrosine Kinase Inhibitors Display High Prevalence of TP53 Mutations and Primary Resistance Mechanisms.
Translational Oncology
Xu, Yanjun Y; Tong, Xiaoling X; Yan, Junrong J; Wu, Xue X; Shao, Yang W YW; Fan, Yun Y
Publication Date: 2018-12
Variant appearance in text: TET2: 3191_3197delTTTTGAC